« Return to News | CROs/Service Providers

Covance Opens New Offices in Brazil and Mexico

Friday, September 25, 2009 09:36 AM

Covance opened new clinical development offices in Sao Paolo, Brazil, and Mexico City, Mexico to further expand the contract research organization’s (CRO’s) services in Latin America and increase access to patients, the company said.

The new offices will support Covance staff in Central America and the Caribbean, as well as Covance’s Santiago, Chile; and Lima, Peru; offices, which opened earlier this year.

The company has provided clinical trial support in Latin America since 1997 with the first office in Buenos Aires, Argentina.

"Our continued expansion in Latin America highlights the region's growing significance in Covance's clinical development service offerings. These new offices increase our access to patients who are currently not receiving medical therapies and will enable us to shorten clinical trial cycle times for our pharmaceutical and biotech clients," said Covance’s vice president and general manager of global clinical development services Wayne Langlois in a statement.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.